6-Gingerol may induce protective autophagy, autophagic cell death and ferroptosis-mediated cell death in prostate cancer cells.

PMID: Oncol Lett. 2022 Jun; 23 (6): 187. Epub 2022 Apr 26. PMID: 35527779 Abstract Title: 6-Gingerol suppresses cell viability, migration and invasion via inhibiting EMT, and inducing autophagy and ferroptosis in LPS-stimulated and LPS-unstimulated prostate cancer cells. Abstract: 6-Gingerol is a bioactive compound isolated from. 6-Gingerol has been shown to have anticancer effects in … Read more

Naringenin in Si-Ni-San formula inhibits chronic psychological stress-induced breast cancer growth and metastasis.

PMID: J Adv Res. 2022 Jun 16. Epub 2022 Jun 16. PMID: 35718080 Abstract Title: Naringenin in Si-Ni-San formula inhibits chronic psychological stress-induced breast cancer growth and metastasis by modulating estrogen metabolism through FXR / EST pathway. Abstract:: Intro duction Chronic psychological stress is a well-established risk factor for breast cancer development. Si-Ni-San (SNS) is … Read more

Identification of active components in Andrographis paniculata targeting on CD81 in esophageal cancer in vitro and in vivo.

PMID: Phytomedicine. 2022 Jul 20; 102: 154183. Epub 2022 May 20. PMID: 35636176 Abstract Title: Identification of active components in Andrographis paniculata targeting on CD81 in esophageal cancer in vitro and in vivo. Abstract: BACKGROUND: Esophageal cancer (EC) is highly prevalent in Eastern Asia (including China) with high rates of mortality. The metastatic tendency in … Read more

Astragaloside IV inhibits the progression of liver cancer.

PMID: Am J Transl Res. 2022; 14 (3): 1551-1566. Epub 2022 Mar 15. PMID: 35422920 Abstract Title: Astragaloside IV inhibits the progression of liver cancer by modulating macrophage polarization through the TLR4 / NF-/B / STAT3 signaling pathway. Abstract: AIM: The purpose of the present research was to investigate the effect and mechanism of Astragaloside … Read more

Exploring the mechanism of cordycepin combined with doxorubicin in treating glioblastoma.

PMID: PeerJ. 2022; 10: e12942. Epub 2022 Feb 15. PMID: 35186504 Abstract Title: Exploring the mechanism of cordycepin combined with doxorubicin in treating glioblastoma based on network pharmacology and biological verification. Abstract: Background: Glioblastoma is the most common and fatal primary malignant tumor in the central nervous system, and the prognosis is poor. Currently, there … Read more